PB1998: WEEKLY OPPOSED TO BI-WEEKLY BORTEZOMIB AS PART OF INDUCTION CHEMOTHERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA IS BETTER TOLERATED AND EQUALLY EFFICIENT: REAL-WORLD DATA FROM A RETROSPECTIVE AUDIT
L. Faulkner,
M. Garg,
C. Suresh
Affiliations
L. Faulkner
1 University Hospitals Leicester, Leicester, United Kingdom
M. Garg
1 University Hospitals Leicester, Leicester, United Kingdom
C. Suresh
1 University Hospitals Leicester, Leicester, United Kingdom